# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035170
Filing Date
2024-08-06
Accepted
2024-08-06 16:04:28
Documents
84
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bcrx-20240630.htm iXBRL | 10-Q | 1493462
2 | EX-10.2 | exhibit102-biocrystxfirsta.htm | EX-10.2 | 6973
3 | EX-10.3 | exhibit103-biocrystpharmac.htm | EX-10.3 | 17580
4 | EX-10.4 | exhibit104-biocrystsipperf.htm | EX-10.4 | 46551
5 | EX-31.1 | bcrx-20240630xexx311.htm | EX-31.1 | 9618
6 | EX-31.2 | bcrx-20240630xexx312.htm | EX-31.2 | 9592
7 | EX-32.1 | bcrx-20240630xexx321.htm | EX-32.1 | 4664
8 | EX-32.2 | bcrx-20240630xexx322.htm | EX-32.2 | 4638
| Complete submission text file | 0001628280-24-035170.txt |  | 8208950

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bcrx-20240630.xsd | EX-101.SCH | 60310
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bcrx-20240630_cal.xml | EX-101.CAL | 67082
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bcrx-20240630_def.xml | EX-101.DEF | 249496
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bcrx-20240630_lab.xml | EX-101.LAB | 724048
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bcrx-20240630_pre.xml | EX-101.PRE | 488571
87 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx-20240630_htm.xml | XML | 1189130

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 241179067
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)